Original antigenic sin in dengue
- PMID: 6824120
- DOI: 10.4269/ajtmh.1983.32.154
Original antigenic sin in dengue
Abstract
Sequential blood samples were obtained from eight Thai children before, during and 3-5 months after hospitalization for dengue shock syndrome. All patients experienced a secondary-type antibody response as evidenced by hemagglutination-inhibition antibody responses in acute and convalescent sera. Dengue 2 viruses were recovered from two patients. In their pre-illness blood sample, all children had monotypic neutralizing antibodies; five to dengue 1, two to dengue 3 and one to dengue 4. The highest neutralizing antibody titers in acute phase and late convalescent sera were to the initial infecting virus type. This report documents for sequential dengue infections the existence of an original antigenic sin antibody response. It may be possible to apply this phenomenon to identify initial dengue serotype infection in individuals experiencing secondary dengue infections, thus helping to clarify the antecedents to dengue shock syndrome.
Similar articles
-
Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak.Am J Epidemiol. 1984 Nov;120(5):653-69. doi: 10.1093/oxfordjournals.aje.a113932. Am J Epidemiol. 1984. PMID: 6496446
-
A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996.Am J Trop Med Hyg. 1999 Sep;61(3):412-9. doi: 10.4269/ajtmh.1999.61.412. Am J Trop Med Hyg. 1999. PMID: 10497982
-
Dengue virus cross-reactive hemagglutination inhibition antibody responses in patients with primary dengue virus infection.Jpn J Infect Dis. 2007 Sep;60(5):267-70. Jpn J Infect Dis. 2007. PMID: 17881865
-
Immunity and immunopathology in dengue virus infections.Semin Immunol. 1992 Apr;4(2):121-7. Semin Immunol. 1992. PMID: 1617166 Review.
-
Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade.Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S830-9. doi: 10.1093/clinids/11.supplement_4.s830. Rev Infect Dis. 1989. PMID: 2665015 Review.
Cited by
-
B cell receptor dependent enhancement of dengue virus infection.PLoS Pathog. 2024 Oct 31;20(10):e1012683. doi: 10.1371/journal.ppat.1012683. eCollection 2024 Oct. PLoS Pathog. 2024. PMID: 39480886 Free PMC article.
-
Immunomodulation in dengue: towards deciphering dengue severity markers.Cell Commun Signal. 2024 Sep 26;22(1):451. doi: 10.1186/s12964-024-01779-4. Cell Commun Signal. 2024. PMID: 39327552 Free PMC article. Review.
-
Immunologic Crosstalk and Host-Specific Immune Signature Associated with Dengue.ACS Omega. 2024 Aug 20;9(36):37418-37429. doi: 10.1021/acsomega.4c02506. eCollection 2024 Sep 10. ACS Omega. 2024. PMID: 39281909 Free PMC article. Review.
-
Immune system gene polymorphisms associated with severe dengue in Latin America: a systematic review.Rev Inst Med Trop Sao Paulo. 2023 Dec 1;65:e58. doi: 10.1590/S1678-9946202365058. eCollection 2023. Rev Inst Med Trop Sao Paulo. 2023. PMID: 38055376 Free PMC article.
-
Antigen-specific T cell responses in SARS-CoV-2 mRNA-vaccinated children.Cell Rep Med. 2023 Dec 19;4(12):101298. doi: 10.1016/j.xcrm.2023.101298. Epub 2023 Nov 27. Cell Rep Med. 2023. PMID: 38016480 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

